Idelalisib for Relapsed Follicular Lymphoma (FL) and Small Lymphocytic Leukemia (SLL) Voluntarily Withdrawn from US Market
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
CURE Educated Patient CLL Webinar
Thursday, August 27, 2020
CURE® is proud to bring additional expert insight to Chronic Lymphocytic Leukemia patients and caregivers on our next Educated Patient® CLL Webinar on Thursday August 27 at 6 p.m ET. On this webinar participants will hear from the experts on topics such as BTK inhibitors, oral vs. infusion treatment options, living with CLL long-term, and shared decision-making. Participants will also have the opportunity to submit questions to be answered live by our expert panel.
Related posts
